Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Dani Olmo’s agent explains his trip to Manchester amid the rumors about Barcelona’s future

Barcelona nervously awaits the resolution of a court case on Friday that will dictate whether it can register Dani Olmo and Pau Víctor. They would not be able to play the rest of the season if they cannot register before the end of the month.

The issue is of particular importance in the case of star signing Dani Olmo, who arrived this summer for €55 million from RB Leipzig. You have a clause in your contract that means if you are not registered, you can leave for free; He was signed up for the first half of the season due to the emergency injury rule.

Recent reports from England have claimed that Manchester City and Arsenal are watching the situation closely, in case they can make a bargain. The fact that his agent Andy Barça was present for Manchester City’s draw against Everton sparked more rumors about Olmo’s future. However, when asked by DM, quoted by MEN, Barça confirmed that he was simply on vacation.

Barcelona has assured that it will be able to register Olmo and Víctor and plans to sell more assets to do so if the court case does not rule in its favor. The Blaugrana are considering selling a package to market their VIP boxes at the renovated Camp Nou for 20 years, for between 100 and 200 million euros.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.